Tokyo, Japan

Mai Imamoto


 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2014-2016

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Mai Imamoto: Innovator in Vascular Health

Introduction

Mai Imamoto is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of vascular health through her innovative research and patents. With a focus on enhancing vascular endothelial function, her work has the potential to impact various health-related applications.

Latest Patents

Mai Imamoto holds 2 patents that showcase her expertise in developing compounds aimed at improving vascular health. Her latest patents include the "Epigallocatechin gallate tetramer and vascular endothelial function improving agent containing the same." This invention provides a compound capable of continuously enhancing nitric oxide (NO) function from vascular endothelial cells, thereby improving vascular endothelial function. The compound is represented by a specific formula wherein R, R, R, and R can each independently be hydrogen or a gallate group. This innovation has applications in food, drink, and pharmaceutical compositions.

Career Highlights

Mai Imamoto is currently associated with Suntory Holdings Limited, a leading company in the beverage and health industry. Her role at the company allows her to apply her research in practical settings, contributing to the development of health-enhancing products.

Collaborations

Mai collaborates with Yuko Fukui, a fellow researcher, to further advance their work in vascular health. Their partnership exemplifies the importance of teamwork in driving innovation and achieving impactful results.

Conclusion

Mai Imamoto's contributions to vascular health through her patents and research highlight her role as a key innovator in the field. Her work not only advances scientific knowledge but also has the potential to improve health outcomes for many individuals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…